KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Non-Current Debt (2016 - 2022)

Medpace Holdings (MEDP) has disclosed Non-Current Debt for 6 consecutive years, with $249.7 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Non-Current Debt changed N/A year-over-year to $249.7 million, compared with a TTM value of $249.7 million through Jun 2022, changed N/A, and an annual FY2018 reading of $79.7 million, down 61.13% over the prior year.
  • Non-Current Debt was $249.7 million for Q2 2022 at Medpace Holdings, up from $55.8 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $249.7 million in Q2 2022 and bottomed at $55.8 million in Q1 2019.
  • Average Non-Current Debt over 3 years is $137.8 million, with a median of $130.4 million recorded in 2018.
  • The sharpest move saw Non-Current Debt increased 22.98% in 2018, then crashed 69.19% in 2019.
  • Year by year, Non-Current Debt stood at $79.7 million in 2018, then crashed by 30.03% to $55.8 million in 2019, then skyrocketed by 347.64% to $249.7 million in 2022.
  • Business Quant data shows Non-Current Debt for MEDP at $249.7 million in Q2 2022, $55.8 million in Q1 2019, and $79.7 million in Q4 2018.